NHS leaders have warned that the cost of supporting people with ADHD and autism is becoming “out of control,” as demand for assessment and treatment continues to place growing pressure on services in England. The warning comes amid a wider debate over how the health system should respond to rising referrals, long waits and the increasing number of patients turning to private care.
Rising demand is testing NHS capacity
The issue has become increasingly visible in recent years, with The BMJ reporting a sharp rise in complaints to NHS services and growing concern about the cost to patients of seeking private assessments. In its latest coverage, the publication highlighted the strain on services as patients and families navigate a system where demand is far outpacing capacity.
According to the report, some patients are paying thousands of pounds for private treatment after encountering delays in the NHS pathway. That pressure is not only affecting patients and families, but also feeding back into the public system, where clinicians are having to manage more complex demand across already stretched services. The BMJ news desk has repeatedly covered the wider impact of workforce shortages, digital delays and access problems across UK care.
What the latest warning means for services
The warning from NHS leaders reflects a broader concern that autism and ADHD support now involves far more than diagnosis alone. Patients often need follow-up care, specialist advice, education support and long-term management, all of which can create sustained demand on clinical teams. In practice, that means any increase in referrals can quickly translate into higher costs and longer queues elsewhere in the system.
The BMJ’s recent reporting suggests the problem is no longer limited to waiting lists; it is also shaping how patients experience the health service, especially when they feel pushed toward private options. That shift raises questions about equity, affordability and whether current NHS pathways are keeping pace with real-world need. Read the latest BMJ medical news
A growing policy challenge for England
For policymakers, the warning adds to mounting pressure to redesign services in a way that is sustainable, clinically appropriate and accessible. The challenge is not simply to reduce costs, but to ensure that people seeking help for neurodevelopmental conditions can obtain support without facing excessive delays or financial barriers.
The debate is likely to remain high on the medical agenda as NHS leaders, clinicians and patient advocates continue to push for a system that can respond to rising need. For now, the message from the latest reporting is clear: demand for ADHD and autism services is accelerating, and the financial consequences are becoming harder for the NHS to absorb.
Photo source: AI-generated or edited image
